[3] [12] It is indicated as an adjunct to reduced-calorie diet and increased physical activity
Provider credentials are publicly displayed and verifiable
Both drugs have reduced diabetes risk, improved blood glucose control, promoted weight loss, and decreased cardiovascular events compared with placebo in selected populations, although the populations, doses, and indications differed
Importantly, tirzepatide carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Liraglutide suppresses atrial electrophysiological changes
When indicated, laboratory markers such as blood sugar trends, insulin sensitivity, or metabolic parameters may be reviewed to ensure the medication is supporting overall health